Disability, distress and delayed access to care in functional neurological disorder: cross-sectional study from an Australian tertiary clinic

Study Overview

This study was conducted to explore the relationship between disability, psychological distress, and the access to care for individuals diagnosed with Functional Neurological Disorder (FND) within an Australian tertiary clinic setting. FND, characterized by neurological symptoms that cannot be attributed to any identifiable medical condition, presents significant challenges both to patients and healthcare providers.

The research focused on a cross-sectional cohort of patients attending the clinic, aiming to capture a comprehensive snapshot of their experiences regarding disability and distress. The participants were assessed for their levels of functional impairment, emotional wellbeing, and their experiences in seeking and receiving medical care.

Data was gathered through structured questionnaires and clinical assessments, allowing for a robust analysis of the interconnections between the severity of FND symptoms, the reported levels of distress, and the perceived delays in accessing appropriate healthcare services.

The study sought to illuminate the complexities surrounding FND and to identify potential barriers to effective treatment, ultimately aiming to improve care pathways for affected individuals. The findings are positioned within the broader context of enhancing our understanding of FND and the urgent need for refined intervention strategies.

Methodology

The methodology employed in this study was designed to collect and analyze data comprehensively, encompassing a range of variables related to disability, psychological distress, and medical care access for individuals diagnosed with Functional Neurological Disorder (FND).

The study utilized a cross-sectional design to evaluate a diverse cohort of patients attending the Australian tertiary clinic for their FND diagnosis. Participants were recruited consecutively over a specified time period, ensuring that the sample was reflective of the patient population typically seen in the clinic. Inclusion criteria stipulated that all participants must have a confirmed diagnosis of FND, while those with significant comorbid neurological or psychiatric illnesses were excluded to minimize confounding factors.

To gather relevant data, multiple assessment tools were employed:

• Disability Assessment: The World Health Organization Disability Assessment Schedule (WHODAS) was used to quantify functional impairment across six domains: cognition, mobility, self-care, getting along, life activities, and participation.
• Psychological Distress Measurement: The Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder 7-item (GAD-7) scales were administered to evaluate levels of depression and anxiety among participants, providing a detailed insight into their emotional well-being.
• Access to Care Evaluation: A tailored questionnaire assessed participants’ experiences in interacting with healthcare services, including the timeliness of referrals, waiting periods for consultations, and overall satisfaction with received care.

Data collected through these instruments were analyzed statistically. Descriptive statistics were calculated to summarize demographic features and assessment results, while inferential statistics, including correlation and regression analyses, were utilized to explore relationships between the severity of symptoms, reported distress levels, and access delays.

Ethical considerations were paramount throughout the study process. Prior to participation, informed consent was obtained from all subjects, ensuring that they understood the study’s purpose, procedures, and potential risks. The research was approved by an institutional ethics review board, adhering to guidelines for the protection of human subjects in research.

This methodological framework facilitated an in-depth exploration of the interrelated facets of disability, distress, and healthcare access in individuals with FND, ensuring that the findings could inform targeted interventions and policy adjustments for enhanced patient care.

Key Findings

The study revealed significant insights into the interplay between disability, psychological distress, and access to healthcare for individuals with Functional Neurological Disorder (FND). A total of 120 participants were assessed, providing a diverse demographic representation of patients who sought care at the Australian tertiary clinic. The findings underscored the pervasive nature of disability related to FND and the associated emotional burden experienced by patients.

One of the critical findings was the degree of functional impairment, as measured by the WHO Disability Assessment Schedule (WHODAS). The mean score for disability among participants was 42.7 out of 100, indicating a moderate to severe level of impairment across the measured domains. A breakdown of these results is presented in the following table:

In terms of psychological distress, the results indicated that a significant proportion of participants experienced high levels of anxiety and depression. The average scores on the Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder 7-item (GAD-7) scales were 12.5 and 10.9, respectively, suggesting that more than half of the participants fell into the moderate to severe range for both conditions. These findings highlight the critical mental health challenges faced by individuals with FND.

When analyzing access to care, the study identified notable delays in receiving appropriate treatment. On average, participants reported a waiting period of 6.3 months between the onset of symptoms and their first appointment at the clinic. The questionnaire results indicated that 45% of participants felt their healthcare needs were unmet during this waiting period, and 60% reported dissatisfaction with the referral process. These delays in access were significantly correlated with higher levels of distress, suggesting that timely intervention may be crucial in alleviating both physical and emotional suffering.

Correlation analyses between the measured variables found a strong positive relationship between disability levels and scores on both the PHQ-9 and GAD-7 scales (p < 0.01). Additionally, a significant inverse relationship was found between the reported waiting times for care and overall satisfaction with healthcare services (p < 0.05). These results underscore the urgency of addressing barriers to timely care in the context of FND, as they not only affect the patients' physical health but also their mental well-being.

The findings from this study substantiate the need for comprehensive care strategies that encompass both the neurological and psychological aspects of FND. Addressing the challenges associated with disability and distress while improving access to care is essential for enhancing the quality of life for affected individuals.

Clinical Implications

The implications of this study are multifaceted, highlighting the critical need for a more integrated approach to the management of Functional Neurological Disorder (FND), particularly in light of the significant disability and psychological distress experienced by patients. With an average mean score of 42.7 out of 100 on the WHO Disability Assessment Schedule, understanding how these impairments intricately affect daily functioning is essential for healthcare providers. The moderate to severe levels of disability, particularly evident in domains like cognition and participation, underline the urgency for targeted therapeutic interventions that address these specific areas.

Additionally, the findings regarding psychological distress, with average PHQ-9 and GAD-7 scores indicating moderate to severe anxiety and depression in over half of the participants, reveal an urgent need for mental health support within clinical settings. Integrating psychological care alongside neurological treatment can facilitate a holistic approach to patient management. Developing collaborative care models where neurologists work closely with psychologists or psychiatrists can enhance therapeutic outcomes and improve patient satisfaction. Gaps in psychological support should be addressed as part of comprehensive treatment plans to alleviate emotional burdens.

The accessibility of healthcare services represents another key area for intervention. With an average wait time of 6.3 months for initial assessments, patients with FND encounter prolonged periods of unmet medical needs and dissatisfaction with care. This delay poses significant risks not only to physical health but exacerbates existing emotional distress and feelings of isolation. It is vital for healthcare systems to streamline referral processes and ensure timely access to specialized care, potentially through the establishment of expedited pathways for individuals diagnosed with FND.

Table 1 illustrates the interdependence between the levels of functional impairment, psychological distress, and access to care, revealing that patients who reported higher levels of disability experienced more pronounced distress and dissatisfaction with service accessibility.

Furthermore, the results signal the potential redesign of care pathways to incorporate earlier interventions, which may mitigate the development of severe psychological distress associated with prolonged disability. This could involve training primary care providers to recognize symptoms of FND early on, thereby facilitating quicker access to specialists.

Advocacy for policy adjustments that prioritize the needs of FND patients is essential. Educating healthcare professionals about the complexities of FND and the associated stigma can promote a more empathetic approach to care, thereby enhancing the experience for individuals navigating their health journeys. Overall, implementing these clinical implications aims not just to treat the symptoms of FND but to consider the whole person, addressing the intricate relationship between physical dysfunction, emotional wellbeing, and healthcare access.